Submitted by Anonymous (not verified) on 20 November 2025 - 13:40
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation: 17/11/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation: 17/11/2025, Status: Authorised